Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema

Fryer, R M, Segreti, J, Banfor, P N, Widomski, D L, Backes, B J, Lin, C W, Ballaron, S J, Cox, B F, Trevillyan, J M, Reinhart, G A, von Geldern, T W·2008·British Journal of Pharmacology
DOI 10.1038/sj.bjp.0707641

Cited by (133)

Items 101–133 of 133

  1. Use of angiotensin receptor – neprilysin inhibitors in heart failure: a paradigm shift
    M. O.E. Irhuma, Muhammed Vally · 2016 · South African Family Practice
  2. New therapeutic options in heart failure. What's on the horizon? An overview
    Eleni S. Nakou, Panagiotis E. Vardas · 2013 · International Journal of Cardiology
  3. Angiotensin Receptor Neprilysin Inhibitor LCZ696: pharmacology, Pharmacokinetics and Clinical Development
    Yue Hua, Ian Wang, Bin Liu, Darren J. Kelly, Christopher Michael Reid, Danny Liew, Yingchun Zhou, Bing Hui Wang · 2016 · Future Cardiology
  4. Novel Blockers of the Renin-Angiotensin-Aldosterone System in Chronic Heart Failure
    Archyut Valluri, Allan D. Struthers, Chim Choy Lang · 2013 · Current Heart Failure Reports
  5. Structural and biochemical characterization of a zinc metallopeptidase from Porphyromonas gingivalis
    Chunyang Feng, Wei‐Li Yu, Yong-Liang Jiang, Rong Mu Xia · 2024 · Biochemical and Biophysical Research Communications
  6. Aminopeptidase P2
    William H. Simmons · 2012 · Elsevier eBooks
  7. Effects of Endopeptidase Inhibition on the Contraction–Relaxation Response of Isolated Human Vaginal Tissue
    Harrina Erlianti Rahardjo, Stefan Ückert, Akmal Taher, Joachim E. Sonnenberg, Wolfgang Kauffels, Djoko Rahardjo, Markus Antonius Kuczyk · 2013 · The Journal of Sexual Medicine
  8. Risk for Angioedema With the Use of Dipeptidyl Peptidase 4 Inhibitors: A Population-Based Cohort Study
    Bin Hong, Hyesung Lee, Jae Hyun Bae, Young Min Cho, Ju-Young Shin · 2025 · The Journal of Allergy and Clinical Immunology In Practice
  9. Effect of Angiotensin Receptor-Neprilysin Inhibitor versus Valsartan on Cardiac Status in Patients with Chronic Heart Failure with Reduced Ejection Fraction: A Randomized Clinical Trial in Rangpur Medical College Hospital, Bangladesh
    Sadia Ghafur, Md. Abu Zahid, Haripada Sarkar, Rabindra Nath Barman, Abdullah Al Mahmud, Mahbubur Rahman, Hasanul Islam · 2020 · Open Journal of Internal Medicine
  10. New Drugs Under Development for Cardiovascular Prevention
    Stéphane Laurent, U. Muscha Steckelings · 2015 · Elsevier eBooks
  11. Pathogenesis of CoViD19—Miscellaneous Mechanisms
    Umair Mallick · 2022 · Springer eBooks
  12. Aneurysm formation and bradykinin
    Friedrich Cameron Luft · 2009 · Journal of Molecular Medicine
  13. Peptide and nonpeptide ligands acting at bradykinin receptors
    François Marceau, Xavier Charest‐Morin, Lajos Gera · 2025 · Elsevier eBooks
  14. Advances in Cardiovascular Pharmacotherapy. VI. Sacubitril-Valsartan, An Angiotensin Receptor-Neprilysin Inhibitor
    Paul S. Pagel, Dustin Hang, Julie K. Freed, George J. Crystal · 2025 · Journal of Cardiothoracic and Vascular Anesthesia
  15. MANAGEMENT OF HYPERTENSION: NEW PERSPECTIVES
    Ж. Д. Кобалава, Yu. V. Kotovskaya, Виллевальде Светлана Вадимовна, И. М. Амирбегишвили, A. E. Solovyova · 2013 · Arterial’naya Gipertenziya (Arterial Hypertension)
  16. Fonction endocrine du cœur
    Samy Talha, François Piquard, Bernard Gény · 2015
  17. New Drugs Under Development for Cardiovascular Prevention
    Stéphane Laurent, U. Muscha Steckelings · 2024 · Elsevier eBooks
  18. Endogenous Vasoactive Peptides
    Randy L. Webb, Gary M. Ksander · 2003 · Wiley eBooks
  19. Wirkung einer Vasopeptidase-Hemmung auf die linksventrikuläre Hypertrophie und Funktion am Modell der 5/6-nephrektomierten Ratte
    Halleck, Fabian · 2012 · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver
  20. B. Hilt svarer:
    Bjørn Hilt · 2015 · Tidsskrift for Den norske legeforening
  21. Re: Ny og bedre medisin mot hjertesvikt
    Erik Waage Nielsen, Knut Tore Lappegård, Harald Thidemann Johansen · 2015 · Tidsskrift for Den norske legeforening
  22. Novel Therapies for Acute Decompensated Heart Failure
    B. Smith, John E. Blair · 2017 · Springer eBooks
  23. Adipose tissue metabolism and cardiometabolic health in obesity
    Stinkens · 2017 · Research Publications (Maastricht University)
  24. Review Article Angiotensin Receptor Neprilysin Inhibition in Heart Failure: Mechanistic Action and Clinical Impact
    Jonathan Buggey, Robert John Mentz, Adam D. DeVore, Eric J. Velazquez · 2015
  25. Sacubitril/Valsartan and Ivabradine: Two Compounds for Heart Failure with Low Ejection Fraction (EFrEF), Acting by Innovative Mechanisms
    Federico Cacciapuoti · 2019 · Journal of Cardiology and Therapy
  26. Angiotensin receptor blockers and angiotensin receptor–neprilysin inhibitors
    John J.V. McMurray · 2022
  27. Inibidores da Neprilisina: Histórico, Farmacologia, Evidência Farmacológico-clínica e Prática Clínica, do Risco de Angioedema ao Pilar Terapêutico na Insuficiência Cardíaca
    Paulo Vinicius Ramos Souza, Vagner Madrini, F. F. Danziato, Félix José Alvarez Ramires · 2024 · ABC Heart Failure & Cardiomyopathy
  28. Neprilysin Inhibitors: History, Pharmacology, Pharmacological-Clinical Evidence, and Clinical Practice, from the Risk of Angioedema to a Pillar of Therapy in Heart Failure
    Paulo Vinicius Ramos Souza, Vagner Madrini, Fábio Fernandes, F. F. Danziato, Félix José Alvarez Ramires · 2024 · ABC Heart Failure & Cardiomyopathy
  29. Aminopeptidase P2
    William H. Simmons · 2025 · Elsevier eBooks
  30. Tumor-Selective Vascular Modulation by Acid-Cleavable Retro-Inverso Bradykinin Conjugates Enhances the Antitumor Efficacy of Nanomedicine
    Anthony Assumang, Hideaki Nakamura, Enoch Appiah, Kevin Kotalík, Masaya Morimitsu, Tomáš Etrych, Mamoru Haratake · 2026 · ACS Omega
  31. BindingDB Entry 50009367: Molecular Basis for Omapatrilat and Sampatrilat Binding to Neprilysin-Implications for Dual Inhibitor Design with Angiotensin-Converting Enzyme.
    BindingDB · 2021 · UC San Diego
  32. BindingDB Entry 50006848: Discovery of TD-0212, an Orally Active Dual Pharmacology AT
    BindingDB · 2021 · UC San Diego
  33. BindingDB Entry 50003195: Molecular Basis for Multiple Omapatrilat Binding Sites within the ACE C-Domain: Implications for Drug Design.
    BindingDB · 2020 · UC San Diego